Recurrence rate of PDOX in each treatment group.

Figshare2015-12-02 更新2026-04-29 收录

肿瘤药效评估

PDOX模型

数据链接：

https://figshare.com/articles/dataset/_Recurrence_rate_of_PDOX_in_each_treatment_group_/1257131 数据链接链接失效反馈

官方服务：

资源简介：

* p = 0.041, compared to FGS only.Recurrence rate of PDOX in each treatment group.

创建时间：

2015-12-02

Are Pt(IV) Prodrugs That Release Combretastatin A4 True Multi-action Prodrugs?

抗肿瘤前药机制

肿瘤药效评估

“Multi-action” Pt(IV) derivatives of cisplatin with combretastatin A4 (CA4) bioactive ligands that are conjugated to Pt(IV) by carbonate are unique because the ligand (IC50 in vitro. The Pt(IV)-CA4

Figshare2021-08-03 更新80

Volume, mass and inhibition rate of tumor (n = 12).

肿瘤药效评估

抗肿瘤实验数据

Volume, mass and inhibition rate of tumor (n = 12).

Figshare2016-09-28 更新20

The anti-tumor effect of Bay 61–3606 and TRAIL in vivo .

肿瘤药效评估

乳腺癌凋亡机制

(A) The mean tumor volumes are presented. After the average volumes of the tumors reached ~100 mm3, mice (n = 5/group) were injected intraperitoneally twice a week with TRAIL (10 mg/kg), Bay 61–3606 (

NIAID Data Ecosystem20

GE inhibited tumor growth in mouse SHR xenografts.

肿瘤药效评估

肿瘤异种移植模型

a. Prevention rate = tumor-free mice number/total mice number; b. Tumor volume (TV) = (length × width2) ×0.532; c. Relative Tumor volume (RTV) = (TV on sacrificing day)/(TV on day 1 of injection

NIAID Data Ecosystem30

IBL-302 PIM/PI3K/mTOR triple kinase inhibitor treatment of patient derived orthotopic xenograft neuroblastoma cells. IBL-302 PIM/PI3K/mTOR triple kinase inhibitor treatment of patient derived orthotopic xenograft neuroblastoma cells

神经母细胞瘤药物机制

PDOX模型

neuroblastoma cells derived from PDOX models were treated with the kinase inhibitor. Overall design: 5 repetitions of control and IBL-302 treated cells were harvest and submitted for RNAseq analysis

NIAID Data Ecosystem20

Recurrence rate of PDOX in each treatment group.

资源简介：

相关数据集